BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16929790)

  • 21. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
    Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C
    Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
    Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
    Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
    Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
    Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
    Tabori U; Nanda S; Druker H; Lees J; Malkin D
    Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Li-Fraumeni syndrome and the p53 gene].
    Thoresen SO
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):887-9. PubMed ID: 1557756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I; Mohr N; Kramer F; Weber BH
    Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA2: a cause of Li-Fraumeni-like syndrome.
    Evans DG; Wu CL; Birch JM
    J Med Genet; 2008 Jan; 45(1):62-3. PubMed ID: 18178637
    [No Abstract]   [Full Text] [Related]  

  • 31. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
    Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
    J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial aggregation of soft tissue sarcomas: a report of three cases from a Li-Fraumeni-like family.
    Narita T; Dobashi Y; Nakamura T; Yokoyama S; Matsuda K
    Arch Pathol Lab Med; 1997 May; 121(5):493-8. PubMed ID: 9167603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.
    Chao MM; Levine JE; Ruiz RE; Kohlmann WK; Bower MA; Petty EM; Mody RJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):1000-4. PubMed ID: 16333835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Li-Fraumeni syndrome and the role of the pediatric nurse practitioner.
    Parsons M
    Clin J Oncol Nurs; 2011 Feb; 15(1):79-87. PubMed ID: 21278043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
    Trková M; Sedlácek Z
    Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare tumor and an ethical dilemma in a family with a germline TP53 mutation.
    Prochazkova K; Foretova L; Sedlacek Z
    Cancer Genet Cytogenet; 2008 Jan; 180(1):65-9. PubMed ID: 18068537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review].
    Xie Y; Zhao WH; Hua Y; Sun Q; Wu PH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1263-1266. PubMed ID: 29237527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A report of a family affected by a Li-Fraumeni type of syndrome with adrenal cortical carcinoma in an adult. A case].
    Massotti G; Tonolini M; Saibene F; Gattoni F; Uslenghi CM
    Radiol Med; 2000 Mar; 99(3):206-9. PubMed ID: 10879177
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
    Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.